Internal Medicine, Hematology · Charlotte, NC
NPI
1548490717
Since 2009
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
248 services
Medicare patients, 2024
93
Average age 71
Drug cost, 2024
$1.1M
361 prescriptions
Company payments, 2025
$7,866
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srinivasa R Sanikommu was code 99215 (office e&m - established), 150 times for 51 patients. In total Srinivasa R Sanikommu billed 248 services in 10 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 150 | 51 | $100.62 | $15K |
| 99215 Office E&M - Established | Office | 24 | 12 | $105.51 | $2,532 |
| 99205 Office E&M - New | Facility | 15 | 15 | $132.16 | $1,982 |
| 99214 Office E&M - Established | Facility | 13 | 12 | $48.05 | $625 |
By year: 2022 $23K for 247 services; 2023 $22K for 224 services; 2024 $25K for 248 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srinivasa R Sanikommu prescribed most often to Medicare patients was Acyclovir, with 43 prescriptions and refills. In total Srinivasa R Sanikommu wrote 361 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 43 | 77 | 12 | $674 |
| Hydroxyurea Generic | 27 | 57 | Under 11 | $956 |
| Tacrolimus Generic | 23 | 23 | Under 11 | $829 |
| Posaconazole Generic | 20 | 20 | Under 11 | $19K |
| Levofloxacin Generic | 18 | 20 | Under 11 | $186 |
| Eliquis Apixaban | 14 | 26 | Under 11 | $15K |
| Cyclosporine Modified Cyclosporine, Modified | 13 | 25 | Under 11 | $6,148 |
| Jakafi Ruxolitinib Phosphate | 13 | 13 | Under 11 | $211K |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $65.25 |
| Fabhalta Iptacopan Hcl | 12 | 12 | Under 11 | $540K |
| Potassium Chloride Generic | 12 | 15 | Under 11 | $348 |
| Famotidine Generic | 11 | 11 | Under 11 | $34.44 |
| Venclexta Venetoclax | 11 | 11 | Under 11 | $15K |
Brand drugs: - claims; generic drugs: 280 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srinivasa R Sanikommu $7,866 ($7,628 in general payments such as food, travel and fees and $238 for research) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $7,827.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.